SELECTIMMUNE PHARMA
SelectImmune Pharma engages in the development and manufacture of immune enhancers as an alternative to antibiotics.
SELECTIMMUNE PHARMA
Industry:
Biopharma Health Care Health Diagnostics Life Science Manufacturing Medical
Founded:
2017-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.selectimmune.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Apache Wordpress Plugins Mobile Non Scaleable Content PHP
Similar Organizations
Roche Diabetes Care
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems.
Sidefarma
Sidefarma engages in the development and manufacture of medicines and other pharmaceutical products.
Wockhardt Bio AG
Wockhardt Bio develops, manufactures and markets pharmaceutical and bio-pharmaceutical formulations.
Current Employees Featured
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-26 | SelectImmune Pharma appoints acting CEO |
Official Site Inspections
http://www.selectimmune.com Semrush global rank: 5.36 M Semrush visits lastest month: 1.56 K
- Host name: 156.234.218.3
- IP address: 156.234.218.3
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
More informations about "SelectImmune Pharma"
Hamlet Pharma and SelectImmune Pharma merge to ... - Hamlet …
Pharma's B share, the offer values SelectImmune at SEK 3.06 per share, which means a premium of approximately 63.25 percent compared to the volume-weighted average price paid …See details»
SelectImmune Pharma - Crunchbase Company Profile & Funding
Organization. SelectImmune Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. SelectImmune Pharma engages in …See details»
PRESS RELEASE Introducing Hamlet BioPharma to investors
A merger of HAMLET Pharma and SelectImmune Pharma was formally decided on May 17th, 2023. The decisions were taken by extra general assemblies in the respective companies. The …See details»
About Hamlet Biopharma - Hamlet BioPharma
The two pharmaceutical companies Hamlet Pharma AB and SelectImmune Pharma AB, listed on the Spotlight Stock Market, has per 2023-05-17 been merged to create a powerful …See details»
SelectImmune Pharma 2025 Company Profile: Valuation, Investors ...
SelectImmune Pharma AB is an innovative biotech company with five well-documented strategies for infection control without antibiotics. The research team behind the innovations has …See details»
SelectImmune About
SelectImmune Pharma AB was founded in 2017. Rather than killing bacteria directly with antibiotics, we develop new ways of equipping the host immune system to fight off the …See details»
SelectImmune Pharma strengthens its organization through the ...
Fredrik Herslow, CEO SelectImmune Pharma, +46 705 91 15 44 [email protected] SelectImmune Pharma is a pharmaceutical company …See details»
Fusion - Hamlet Pharma
Mar 31, 2023 Styrelserna för Hamlet Pharma AB (”Hamlet Pharma”) och SelectImmune Pharma AB (”SelectImmune”) offentliggjorde den 31 mars 2023 att styrelserna för båda bolagen …See details»
Q3 - Hamlet BioPharma
SelectImmune's shareholders. Through the Merger and Acquisition of Linnane Projects AB ("Linnane Projects"), the various sub-projects are established in an organization that can …See details»
SelectImmune Pharma - Products, Competitors, Financials, …
About SelectImmune Pharma. SelectImmune Pharma is a pharmaceutical company. It specializes in developing immune enhancers to complement antibiotics. Its research revolves around …See details»
SelectImmune Pharma AB - VentureRadar
Find out more about SelectImmune Pharma AB including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and …See details»
SelectImmune Pharma - Craft
SelectImmune Pharma is a pharmaceutical company that develops immunotherapies as alternatives to antibiotics. It is engaged in the research and clinical trials of immunity-boosting …See details»
Select Immune 2023 - Hamlet BioPharma
Proposed merger between SelectImmune Pharma AB and Hamlet Pharma AB to create a combined company in drug development for the treatment and prevention of cancer and …See details»
SelectImmune Pharma AB - Drug pipelines, Patents, Clinical trials
Explore SelectImmune Pharma AB with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Infectious Diseases, Technology Platform:Small molecule drug, …See details»
SelectImmune Pharma - Funding, Financials, Valuation & Investors
Jun 26, 2019 Organization. SelectImmune Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... SelectImmune Pharma is registered under …See details»
First patient in – a new treatment option for patients with bladder …
CEO (acting), SelectImmune Pharma AB Tel: +46 733 38 13 44 E-mail: [email protected] Catharina Svanborg Chairman SelectImmune Pharma …See details»
SelectImmune Collaborates with Lonza to Develop an …
Jun 21, 2021 Lund, Sweden and Basel, Switzerland, 21 June 2021 – SelectImmune Pharma, a pharmaceutical company developing novel immunotherapeutics and alternatives to antibiotics, …See details»
SelectImmune Pharma - Contacts, Employees, Board Members
Organization. SelectImmune Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
SelectImmune News - hamletbiopharma.com
H amlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and …See details»
Types of data requested to inform May 2025 COVID-19 vaccine …
Mar 25, 2025 The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 …See details»